➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
McKinsey
Merck
Mallinckrodt
Harvard Business School

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Human cytomegalovirus immune globulin - Biologic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for human cytomegalovirus immune globulin
Recent Clinical Trials for human cytomegalovirus immune globulin

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Shanghai General Hospital, Shanghai Jiao Tong University School of MedicinePhase 4
M.D. Anderson Cancer CenterPhase 2
The Hospital for Sick ChildrenPhase 4

See all human cytomegalovirus immune globulin clinical trials

Patent Text Search: US Patents for human cytomegalovirus immune globulin

These patents were identified by searching patent claims

Supplementary Protection Certificates for human cytomegalovirus immune globulin

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
30/2001 Austria   Start Trial PRODUCT NAME: RECOMBINANTES HUMANES OSTEOGENES PROTEIN-1 (OP 1)
2018 00020 Denmark   Start Trial PRODUCT NAME: AFUCOSYLERET ANTISTOF, DER BINDER TIL ALFA-UNDERENHEDEN AF DEN HUMANE INTERLEUKIN-5-RECEPTOR, SAERLIGT BENRALIZUMAB ELLER EN TERAPEUTISK AEKVIVALENT VARIANT DERAF, SOM ER BESKYTTET AF GRUNDPATENTET; REG. NO/DATE: EU/1/17/1252 20180110
/2001 Austria   Start Trial PRODUCT NAME: RECOMBINANTES HUMANES OSTEOGENES PROTEIN-1 (OP 1); REGISTRATION NO/DATE: EU/1/01/179/001 20010517
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Baxter
McKinsey
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.